TAILIEUCHUNG - Báo cáo hóa học: " Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma"

Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma | Eton et al. Journal of Translational Medicine 2010 8 9 http content 8 1 9 JOURNAL OF TRANSLATIONAL MEDICINE RESEARCH Open Access Autologous tumor-derived heat-shock protein peptide complex-96 HSPPC-96 in patients with metastatic melanoma Omar Eton1 Merrick I Ross2 Mary Jo East1 Paul F Mansfield2 Nicholas Papadopoulos1 Julie A Ellerhorst3 Agop Y Bedikian1 Jeffrey E Lee2 Abstract Background Glycoprotein-96 a non-polymorphic heat-shock protein associates with intracellular peptides. Autologous tumor-derived heat shock protein-peptide complex 96 HSPPC-96 can elicit potent tumor-specific T cell responses and protective immunity in animal models. We sought to investigate the feasibility safety and antitumor activity of HSPPC-96 vaccines prepared from tumor specimens of patients with metastatic melanoma. Methods Patients with a Karnofsky Performance Status 70 and stage III or stage IV melanoma had to have a metastasis 3 cm in diameter resectable as part of routine clinical management. HSPPC-96 tumor-derived vaccines were prepared in one of three dose levels 25 or 100 pg dose and administered as an intradermal injection weekly for 4 consecutive weeks. In vivo induction of immunity was evaluated using delayed-type hypersensitivity DTH to HSPPC-96 irradiated tumor and dinitrochlorobenzene DNCB . The g-interferon IFNg ELISPOT assay was used to measure induction of a peripheral blood mononuclear cell response against autologous tumor cells at baseline and at the beginning of weeks 3 4 and 8. Results Among 36 patients enrolled 72 had stage IV melanoma and 83 had received prior systemic therapy. The smallest tumor specimen from which HSPPC-96 was prepared weighed 2 g. Twelve patients including 9 with stage IV and indicator lesions had a negative DNCB skin test result at baseline. All 36 patients were treated and evaluable for toxicity and response. There were no serious toxicities. There were no observed DTH responses to HSPPC-96 or to .

TÀI LIỆU LIÊN QUAN
TAILIEUCHUNG - Chia sẻ tài liệu không giới hạn
Địa chỉ : 444 Hoang Hoa Tham, Hanoi, Viet Nam
Website : tailieuchung.com
Email : tailieuchung20@gmail.com
Tailieuchung.com là thư viện tài liệu trực tuyến, nơi chia sẽ trao đổi hàng triệu tài liệu như luận văn đồ án, sách, giáo trình, đề thi.
Chúng tôi không chịu trách nhiệm liên quan đến các vấn đề bản quyền nội dung tài liệu được thành viên tự nguyện đăng tải lên, nếu phát hiện thấy tài liệu xấu hoặc tài liệu có bản quyền xin hãy email cho chúng tôi.
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.